Provided is Oxidized Regenerated Cellulose (ORC) and/or Oxidized Cellulose (OC)； and a glycolytic dependent compound for use in enhancing toxicity of the glycolytic dependent compound towards a cell, tissue and/or organ e.g. a diseased cell, tissue and/or organ, wherein the ORC and/or OC； and the glycolytic dependent compound are contacted with the cell, tissue and/or organ in a non-blended form.
